Navigation Links
Alzheimer's disease in mice alleviated promising therapeutic approach for humans
Date:11/25/2012

Alzheimer's disease is one of the most common causes of dementia. In Germany and Switzerland alone, around 1.5 million people are affected, and forecasts predict a doubling of the number of patients worldwide within the next 20 years. The accumulation of particular abnormal proteins, including amyloid- (Aβ) among others, in patients' brains plays a central role in this disease. Prof. Frank Heppner from the Department of Neuropathology at Charit and his colleague Prof. Burkhard Becher from the Institute for Experimental Immunology at the University of Zurich were able to show that turning off particular cytokines (immune system signal transmitters) reduced the Alzheimer's typical amyloid- deposits in mice with the disease. As a result, the strongest effects were demonstrated after reducing amyloid- by approximately 65 percent, when the immune molecule p40 was affected, which is a component of the cytokines interleukin (IL)-12 and -23.

Relevant for human therapy

Follow-up experiments also relevant for humans showed that substantial improvements in behavioral testing resulted when mice were given the antibody blocking the immune molecule p40. This effect was also achieved when the mice were already showing symptoms of the disease. Based on the current study by Prof. Heppner's and Prof. Becher's team, the level of p40 molecules is higher in Alzheimer's patients' brain fluid, which is in agreement with a recently published study by American colleagues demonstrating increased p40 levels in blood plasma of subjects with Alzheimer's disease, thus showing obvious relevance for human therapy.

The significance of the immune system in Alzheimer's research is the focus of current efforts. Prof. Heppner and Prof. Becher suspect that cytokines IL-12 and IL-23 themselves are not causative in the pathology, and that the mechanism of the immune molecule p40 in Alzheimer's requires additional clarification. However, they are convinced that t
'/>"/>

Contact: Prof. Burkhard Becher
becher@immunology.uzh.ch
41-446-353-703
University of Zurich
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. Short DNA strands in the genome may be key to understanding human cognition and diseases
2. Discovery of molecular pathway of Alzheimers disease reveals new drug targets
3. Scripps Research Institute team identifies a potential cause of Parkinsons disease
4. Yeast protein breaks up amyloid fibrils and disease protein clumps differently
5. Scientists question the designation of some emerging diseases
6. Call for global monitoring of infectious diseases in dogs and cats
7. Cells from skin create model of blinding eye disease
8. New drug target found for cystic fibrosis lung disease
9. Researchers test solution to fungal disease of ash trees
10. Daily multivitamin use does not reduce cardiovascular disease risk in men
11. Berkeley Lab scientists help develop promising therapy for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Alzheimer's disease in mice alleviated promising therapeutic approach for humans
(Date:6/17/2013)... in patients with severe brain infections in Vietnam. Further ... responsible for the symptoms of disease. , The virus ... 644 patients with severe brain infections in the study, ... the 122 patients with non-infectious brain disorders that were ... system are often fatal and patients who do survive, ...
(Date:6/17/2013)... in Wayne State University,s Department of Physics kicked ... Experience for Undergraduates (REU) program. This program aims ... research in astrophysics, and in particle and nuclear ... professor of physics in Wayne State,s College of ... of the grant, the student participants will work ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
Breaking Biology News(10 mins):New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3Wayne State welcomes undergraduates from around the US for physics research experience 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... genetic screening (PGS) has been one,of the most hotly ... years. None of the trials,carried out so far has ... European Society of Human,Reproduction and Embryology (ESHRE) Task Force ... if a novel,method of doing PGS using polar body ...
... signal molecule made by the human body that triggers the ... according to new research published today in Nature Medicine ... say that if scientists could block this signal, it may ... arthritis is the most common autoimmune disease, affecting around 1 ...
... fans are in awe of what their football heroes can ... remains strangely mysterious. Although being in excellent physical condition undoubtedly ... can turn an average bloke into a Ronaldo. Now, scientists ... this "something else" might be. Dr. Robbie Wilson will talk ...
Cached Biology News:ESHRE launches international study of polar body screening 2New trigger for chronic inflammation in rheumatoid arthritis discovered 2What makes a great footballer? 2
(Date:6/18/2013)... The human skin is the largest organ, yet many do ... Similar to the liver, or heart, the skin must be ... Recent reports from the mankatofreepress.com explained how caring for the ... other life supporting organs. The article suggests several types of ... the appearance of skin, and fight off acne causing factors. ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... LONDON , June 18, 2013 /PRNewswire/ ... leading international investment research firm, announces the ... (BIO.PA), a French biopharmaceutical company developing and ... supportive care indications.      (Logo: ... a comprehensive report examining the investment merits ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... Feb. 26 Biomerix Corporation announced today that it ... clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), ... ingrowth and can be utilized in a variety of ... hernias. With more than 700,000 procedures per year, inguinal ...
... Feb. 26 ThermoGenesis, Corp. (Nasdaq: KOOL ), ... and store adult stem cells, said today that the FDA ... of certain lots of AXP disposable bagsets that it announced ... recall was not the result of any safety issues; the ...
... SOPHIA ANTIPOLIS, France, February 26 NicOx,S.A. (NYSE ... for,full year 2008 and provided an overview of ... investigational,drug for the treatment of the signs and ... Michele Garufi, Chief Executive Officer of NicOx, ...
Cached Biology Technology:Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 2Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 4Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 5Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 6Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 7Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 8Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 9Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 10Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 11Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 12Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 13Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 14Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 15
... frozen Sf9 Insect Cells are derived from the ... for optimal growth, use in transfections, plaque assays, ... frozen in a protocol that optimizes recovery of ... growth in serum-free BacVector Insect Cell Medium and ...
... software package that provides crystallographers with ... buffer creation, set-up of experimental conditions ... The software helps crystallographers through the ... crystallography: Design of ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit can be ...
Biology Products: